Domestic markets traded lackluster on Tuesday and ended nearly unchanged in the absence of any significant trigger. In today’s trade, shares of Vedanta, Adani Power, Bajaj Finance, IndusInd Bank, BPCL among others will be in focus due to various news developments and fourth quarter results. Vedanta, Adani Power, IOC, Varun BeveragesShares of Vedanta, Adani Power,…
READ MOREDomestic markets began the holiday-shortened week on a strong note, gaining over 2%, supported by positive global cues. In today’s trade, shares of Wipro, Angel One, Gensol Engineering, IndusInd Bank, IREDA, MGL among others will be in focus due to various news developments and corporate earnings. Wipro, Angel OneShares of Wipro and Angel One will…
READ MOREMarkets came under pressure and declined by nearly one and a half percent, largely weighed down by weak global cues. In today’s trade, shares of Nykaa, Delhivery, IndusInd Bank, Mazagon Dock, ITC among others will be in focus due to various news developments and third quarter updates. NykaaNykaa’s consolidated net revenue growth is expected to…
READ MOREThe markets paused after six consecutive sessions of gains, closing on a flat note. In today’s trade, shares of Maruti, ONGC, IREDA, Federal Bank, TVS Motor among others will be in focus due to various news developments. Maruti SuzukiMaruti Suzuki received a draft tax assessment of Rs 2,666 crore for FY22, but the company expects…
READ MOREIndian equity indices opened in the red on Friday, snapping a four-session gaining streak, dragged by IT stocks amid concerns over discretionary spending in the U.S.The BSE Sensex was down 114 points, or 0.15%, at 76,234, while the Nifty50 slipped 14 points, or 0.06%, to 23,176 around 9:19 am. The Nifty IT index dropped over…
READ MOREDomestic markets closed marginally lower last week, reflecting a consolidative tone amid mixed global cues. In today’s trade, shares of Dr Reddy’s, Shilpa Medicare, Voltas, TCS, Tata Motors among others will be in focus due to various news developments. Zydus LifeZydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to…
READ MORE